DocGo Inc (NASDAQ: DCGO)’s stock price has decreased by -1.31 compared to its previous closing price of 1.53. However, the company has seen a 5.59% increase in its stock price over the last five trading sessions. businesswire.com reported 2025-06-02 that NEW YORK–(BUSINESS WIRE)–DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health and medical transportation services, today announced that Lee Bienstock, Chief Executive Officer, will participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9th from 4:00 – 4:35 PM Eastern Time, and hold 1×1 meetings as well. A webcast of the event will be available on the investor relations section of DocGo’s website at ht.
Is It Worth Investing in DocGo Inc (NASDAQ: DCGO) Right Now?
DCGO has 36-month beta value of 0.95. Analysts have mixed views on the stock, with 3 analysts rating it as a “buy,” 1 as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for DCGO is 85.90M, and currently, short sellers hold a 5.77% ratio of that float. The average trading volume of DCGO on June 13, 2025 was 1.07M shares.
DCGO’s Market Performance
DCGO’s stock has seen a 5.59% increase for the week, with a 0.67% rise in the past month and a -47.39% fall in the past quarter. The volatility ratio for the week is 3.71%, and the volatility levels for the past 30 days are at 3.88% for DocGo Inc The simple moving average for the past 20 days is 5.08% for DCGO’s stock, with a -55.18% simple moving average for the past 200 days.
Analysts’ Opinion of DCGO
Deutsche Bank, on the other hand, stated in their research note that they expect to see DCGO reach a price target of $2.85, previously predicting the price at $5. The rating they have provided for DCGO stocks is “Hold” according to the report published on February 28th, 2025.
BTIG Research gave a rating of “Buy” to DCGO, setting the target price at $15 in the report published on August 18th of the previous year.
DCGO Trading at -20.65% from the 50-Day Moving Average
After a stumble in the market that brought DCGO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -73.39% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at DCGO starting from Burdiek Michael J, who purchase 10,000 shares at the price of $1.33 back on May 23 ’25. After this action, Burdiek Michael J now owns 641,560 shares of DocGo Inc, valued at $13,300 using the latest closing price.
Burdiek Michael J, the Director of DocGo Inc, purchase 15,000 shares at $1.43 during a trade that took place back on May 15 ’25, which means that Burdiek Michael J is holding 631,560 shares at $21,450 based on the most recent closing price.
Stock Fundamentals for DCGO
Current profitability levels for the company are sitting at:
- -0.0 for the present operating margin
- 0.33 for the gross margin
The net margin for DocGo Inc stands at -0.0. The total capital return value is set at -0.0. Equity return is now at value -0.21, with -0.14 for asset returns.
Based on DocGo Inc (DCGO), the company’s capital structure generated 0.16 points at debt to capital in total, while cash flow to debt ratio is standing at 1.49. The debt to equity ratio resting at 0.2. The interest coverage ratio of the stock is -0.8.
Currently, EBITDA for the company is 45.8 million with net debt to EBITDA at -1.18. When we switch over and look at the enterprise to sales, we see a ratio of 0.25. The receivables turnover for the company is 2.91for trailing twelve months and the total asset turnover is 1.21. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.44.
Conclusion
To put it simply, DocGo Inc (DCGO) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
